Oculus to unveil the Corvis® ST and the Pentacam® at the ESCRS

Article

Oculus will be presenting its new Corvis ST device at the ESCRS exhibition in Vienna this year.

Oculus will be presenting its new Corvis® ST device at the ESCRS exhibition in Vienna this year.

The device enables the surgeon to view the reaction of the cornea on an air impulse. This is conducted using a high-speed Scheimpflug camera and then displayed on the control panel in ultra-slow-motion.

Visiting the Oculus booth B614 will be an opportunity to learn about the device and other biomechanical properties. Oculus invites you to particpate in a satellite meeting on Monday 19th September, 1pm, in room Lehar 2 of the Messe Wien Congress Centre. Several guest speakers will be present.

Other Oculus products presented at the stand will include: the Pentacam® HR Premium edition Keratograph with tearfilm scanning, the PARK 1® 3-in-1 pachymeter, refraktometer and keratometer, the SDI®/BIOM® system, the perimeters Easyfield® and Centerfield® 2 and the slit lamp camera system ImageCam®.

For more information

Oculus website.

Click here to email Oculus

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.